Patent · US Active

MUC16 specific chimeric antigen receptors and uses thereof

US11319380B2 · kind B2 · utility

1Cited by

9References

11Claims

0Family size

Assignee

Precigen, Inc. · US

Inventors

Helen Sabzevari · Blacksburg, US
Rutul Shah · Boyds, US

Key dates

Filing date	Jun 4, 2019
Grant date	May 3, 2022
Priority date	—
Expiry date	Jun 4, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2510/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are chimeric antigen receptors (CARs) for cancer therapy, and more particularly, CARs containing a scFv from an anti-MUC16 monoclonal antibody. Provided are immune effector cells containing such CARs, and methods of treating proliferative disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.